News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Anavex (AVXL) Plummeted on Phase IIa Alzheimer's Results "Considered" Positive     7/28/2016
Tobira (TBRA) Stock Loses More Than Half Its Value After Phase IIb Trial Miss     7/25/2016
Vtesse Bags Another $17 Million to Support Further Product Development and Expand Ongoing Clinical Trials     7/25/2016
Merck & Co. (MRK) Nabs Breakthrough Tag for Ebola Zaire Vaccine From the FDA and PRIME Status From EMA     7/25/2016
Why Investors Should Pay Attention to Seattle Genetics (SGEN)' Drug Trial     7/22/2016
Juno (JUNO) Stock Falls Again After Correcting Number of Trial Deaths     7/18/2016
SAGE Therapeutics (SAGE)' Stock Explodes as Drug Eliminates Postpartum Depression in Mid-Stage Study     7/14/2016
Juno (JUNO) Soars After the FDA OKs Restart of Clinical Trial     7/14/2016
3 Nauseating Clinical Trial Flops of 2016 So Far     7/12/2016
Juno (JUNO) Halts CAR-T Cancer Trial After Three Patient Deaths     7/11/2016
Sucampo (SCMP) Terminates Development of Cobiprostone Following Phase II Data     7/11/2016
AbbVie (ABBV)'s $175 Million Gamble Pays Off as Ablynx (ABLYF) RA Drug Meets Goal in Phase II Study     7/8/2016
Pfizer (PFE) Stock Climbs With Positive Renal Cancer Phase III Data     7/8/2016
This Year’s Top 10 Disappointing Clinical Trials—So Far!     7/6/2016
Shire (SHPG)'s Retinopathy Treatment Fails to Meet Primary Endpoint in Phase II     7/1/2016

Featured Stories
In Juno (JUNO) Patient Deaths, Echoes Seen Of Earlier Failed Company Dendreon (DNDN)     7/11/2016
ASCO2016: What's Next For Cancer-Killing T-Cells After Strong ASCO Showings     6/8/2016
Down's Syndrome 'Can Be Treated With Green Tea,' Centre for Genomic Regulation Study     6/7/2016
Pharma's Big New Cancer Drug May Be An Old Red Dye     2/26/2016
Why Investors Shouldn't Freak Out Over Vertex (VRTX)'s Latest Trial Results     3/24/2015
Newcomers Like Aerie Pharmaceuticals, Inc. (AERI), Inotek Pharmaceuticals Corporation Aim to Shake Up Big Pharma With New Wave of Glaucoma Drugs     2/10/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Retrenches, And Searches For Answers, After Failed Trial     5/22/2014
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research?     4/4/2014
Popular Weight-Lifting Supplement May Slow Huntington Disease, Massachusetts General Hospital Study     2/11/2014
Dawn of A New Sleep Drug at Merck & Co., Inc. (MRK)?     7/19/2011
Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study     1/28/2011
Experimental Drug Panobinostat Shows Little Activity In MDS Patients, Sarah Cannon Research Institute Study     12/30/2010
Cytokinetics, Inc. (CYTK) Drug Helps ALS Patients in Small Trial     12/13/2010
American Society of Hematology: Novel Hodgkin Drug 'Dramatic' in Refractory Patients, City of Hope Study     12/7/2010
American College of Rheumatology: Anti-IL17 Drug Misses Endpoint in RA Trial, Stanford University Study     11/11/2010
Eli Lilly (LLY) Release: New Studies Suggest Relationship Between Tau Pathology And Progression Of Alzheimer's Disease     7/28/2016
Oramed (ORMP) Reports Additional Phase IIb Oral Insulin Study Data Demonstrating Significant Lowering Of Glucose Levels Vs Placebo     7/28/2016
Chase Pharma Presents Phase 2 Results For CPC-201 At 2016 Alzheimer’s Association International Conference     7/28/2016
Chugai Pharma's Emicizumab Showed Continued Benefits In Patients With Hemophilia A     7/28/2016
vTv Therapeutics Announces Presentation Of Phase 2b Azeliragon Results At The 2016 Alzheimer’s Association International Conference (AAIC)     7/28/2016
Millendo Therapeutics Announces Publication Of Positive Phase 2a Data For MLE4901 For The Treatment Of Polycystic Ovary Syndrome     7/28/2016
Caladrius Biosciences (CLBS) Receives FDA Fast Track Designation For CLBS03 To Treat Recent Onset Type 1 Diabetes     7/28/2016
Agenus (AGEN) Reports Second Quarter 2016 Financial Results And Operational Progress     7/28/2016
Nektar Therapeutics (NKTR) To Announce Financial Results For The Second Quarter 2016 On Wednesday, August 3, 2016, After Close Of U.S.-Based Financial Markets     7/28/2016
Karyopharm (KPTI) To Present Updated Phase II Clinical Data From SIGN Study At European Society Of Medical Oncology 2016 Annual Meeting     7/28/2016
Neurovance Announces Positive Centanafadine Phase 2b Results For Adult ADHD, And Plans For Phase 3 Trials     7/27/2016
Gamida Cell Announces First Patient With Sickle Cell Disease Transplanted In Phase 1/2 Study Of Cordin As The Sole Graft Source     7/27/2016
LSK BioPharma Announces Successful Outcome From End-Of-Phase 2 Meeting With FDA     7/26/2016
Poxel Announces Publication Of Important New Mechanism Data For Imeglimin Relating To Insulin Secretion In The Treatment Of Type 2 Diabetes     7/26/2016
Parion Sciences Announces Initiation Of Phase II Clinical Trial Of P-321 For The Treatment Of Dry Eye Disease     7/26/2016

More News
No News Posted on that date

Career Tips
Brexit Schmexit: What This Mess Means for Life Science Jobs     7/28/2016
Job Seekers Take Note: Challenges Faced by Life Science Employers     7/28/2016
The ROI of Gratitude: Two Biotechs Getting It Right     7/18/2016
Top 14 Life Science Jobs in California     7/14/2016
Top 5 Bay Area Biomed Hot Spots     6/30/2016
Inside the Biotech Employer's Head: Job Interview Questions That You Should Be Ready to Answer     6/16/2016
What’s at the Heart of Alnylam (ALNY)'s Company Culture?     6/3/2016
Jobs Outlook for the Life Science Class of 2016     6/2/2016
Top 20 Entry-Level Life Science Jobs in Massachusetts     5/19/2016
Eli Lilly (LLY) and Regeneron (REGN) Tips: How to Find Your First Biopharma Job Right Out of College     5/19/2016
Life Science Ranks Among Top 9 College Majors to Get a Job     5/5/2016
10 Best U.S. States for Working Moms     5/5/2016
The Highest Paying Life Sciences Jobs     4/21/2016
4 Things New Life Science Graduates Need to Know to Land that First Job     4/21/2016
Talent Connect Draws Scores of Life Science Companies in Massachusetts     4/13/2016

Other News Sources
//-->